Medically reviewed by Corinne Savides Happel, MD Allergies don't cause psoriasis, but you may be more likely to have ...

Studies involving multiple aspects of plaque psoriasis evolution, persistence, and progression have produced clues and ...

SALES: The group's first-quarter sales should come at $13.00 billion, according to a consensus of analysts' estimates compiled by Visible Alpha. This compares with $11.83 billion the year before. In ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

and adherence among psoriasis patients treated with different biologics including tildrakizumab, risankizumab, guselkumab, and ustekinumab, with implications for clinical decision-making based on ...

With the new manufacturing capacity, 100% of its key medicines for U.S. patients will be made in the U.S., Novartis said late Thursday. The company is one of Europe’s biggest dr ...

The insurer argued the policyholder had suppressed the condition of psoriasis in her proposal form and hence was not entitled to the claim. After hearing the arguments, the commission stated ...

Icotrokinra had more significant improvements than placebo for multiple skin clearance measures following 16 weeks of treatment for plaque psoriasis in adolescents and adults. Icotrokinra is ...

Indeed, I think the dose was slightly higher, given the standardly used dosing schedule: The recommended dose of COSENTYX® (secukinumab) for moderate-severe plaque psoriasis is 300 mg.† ...

EC president Ursula von der Leyen is scheduled to hold a call with the European pharmaceuticals industry. Credit: VYACHESLAV OSELEDKO via Getty Images. European Commission (EC) President Ursula von ...

Art Garfunkel is breaking the sound of silence around his experience with plaque psoriasis. The singer, one half of the folk-rock duo Simon & Garfunkel, has teamed with Sun Pharma to discuss how ...